CAVARAPE, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 4.996
EU - Europa 1.582
AS - Asia 293
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 3
AF - Africa 1
OC - Oceania 1
Totale 6.880
Nazione #
US - Stati Uniti d'America 4.956
UA - Ucraina 566
IT - Italia 390
CN - Cina 218
DE - Germania 203
FI - Finlandia 180
IE - Irlanda 97
SE - Svezia 80
CA - Canada 39
TR - Turchia 35
GB - Regno Unito 33
VN - Vietnam 16
IN - India 12
BE - Belgio 11
RU - Federazione Russa 8
IR - Iran 7
AT - Austria 4
EU - Europa 4
FR - Francia 4
HK - Hong Kong 2
UY - Uruguay 2
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
EG - Egitto 1
ES - Italia 1
JP - Giappone 1
KR - Corea 1
NL - Olanda 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
TW - Taiwan 1
Totale 6.880
Città #
Woodbridge 628
Ann Arbor 509
Fairfield 450
Jacksonville 408
Houston 389
Chandler 366
Ashburn 251
Dearborn 230
Wilmington 224
Seattle 192
Cambridge 151
San Mateo 130
Beijing 112
Udine 104
Princeton 100
Dublin 97
Izmir 35
Ottawa 34
San Diego 32
Trieste 23
Hefei 22
Ogden 22
Milan 19
Boardman 18
Dong Ket 16
Norwalk 16
Kunming 14
Des Moines 13
New York 13
Brussels 11
Nanjing 10
Rome 9
Falls Church 8
Pignone 7
Redmond 7
Vicenza 7
Washington 7
Fuzhou 6
Wuhan 6
Andover 5
Jinan 5
Nanchang 5
Simi Valley 5
Toronto 5
Turin 5
Zhengzhou 5
Helsinki 4
Maserada sul Piave 4
Murano 4
Padova 4
Tavagnacco 4
West Jordan 4
Augusta 3
Chengdu 3
Florence 3
Fontanafredda 3
Grafing 3
Guangzhou 3
Leawood 3
Pune 3
Venezia 3
Verona 3
Vienna 3
Auburn Hills 2
Baotou 2
Bari 2
Castellammare di Stabia 2
Chicago 2
Chongqing 2
Crema 2
Henderson 2
Hong Kong 2
Maldonado 2
Phoenix 2
Piemonte 2
Porcia 2
Quzhou 2
Rovigo 2
Saint Petersburg 2
Scorzè 2
Shanghai 2
Shaoxing 2
Siena 2
Torino 2
Torre Del Greco 2
Zanjan 2
Zollino 2
Albenga 1
Bologna 1
Bovezzo 1
Cairo 1
Caivano 1
Camino al Tagliamento 1
Cesena 1
Changsha 1
Chaoyang 1
Codroipo 1
Como 1
Crotone 1
Dugenta 1
Totale 4.849
Nome #
Effects of angiotensin II, arginine vasopressin and tromboxane A2 in renal vascular bed: role of rho-kinase 159
Farmaci antidislipidemici 141
Endothelin and endothelium-derived relaxing factor control of basal renovascular tone in hydronephrotic rat kidneys 121
Clinical Features of renal vascular involvment in systemic diseases. 120
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 119
ANG II- and TxA(2)-induced mesenteric vasoconstriction in rats is mediated by separate cell signaling pathways 118
The emergent cardiovascular risk factors and organ damage in arterial hypertension 113
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial. 113
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 111
Hyperglycemia counterbalances the antihypertensive effect of glutathione in diabetic patients: evidence linking hypertension and glycemia through the oxidative stress in diabetes mellitus 107
Effects of BQ-123 on systemic and renal hemodynamic responses to endothelin-1 in the rat split hydronephrotic kidney 106
Role of nitric oxide (NO) in renal autoregulation - Observations by intravital microscopy 103
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 103
Heart failure in the elderly: A geriatric syndrome. Picture of the modern situation 101
Role of endothelin and endothelium-derived relaxing factor in control of basal vascular tone in rat kidneys 100
Endotoxin priming and liver damage by experimental duodenal obstruction in the rat 100
Contribution of endothelin receptors in renal microvessels in acute cyclosporine-mediated vasoconstriction in rats 100
Endotoxin priming exacerbates acute reflux pancreatitis in the rat 100
Influence of endothelium-derived relaxing factor on renal microvessels and pressure-dependent vasodilation 98
Hypertension and type 2 diabetes: lights and shadows about causality 97
Insulin receptors and renal sodium handling in hypertensive fructose-fed rats 96
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial. 95
Rho-kinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo 93
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes. 93
Insulin sensitivity in patients with primary aldosteronism: a follow-up study 92
Role of endothelin and endothelium-derived relaxing factor in renal microcirculation 91
High-fructose diet decreases catalase mRNA levels in rat tissues. 89
Correlazioni clinico-prognostiche del diabete mellito in pazienti con arteriopatia degli arti inferiori sintomatica:dati preliminari 88
Henoch-Schönlein purpura in a patient with diabetic nephropathy and vascular complications 88
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a) 88
Lp(a), diabete e rivascolarizzazione endovascolare agli arti inferiori: dati di follow-up a 5 anni 88
Effects of distinct endothelin receptor antagonists on cyclosporine-induced renal vasoconstriction 87
Renal hyperfiltration and increased prevalence of cystic disease in patients with primary aldosteronism 86
A multidisciplinary approach in the treatment and management of patients with Eating Disorders: our experience in Udine 82
Different cell signaling pathways for angiotensin II and thromboxane-A2 in renal microcirculation 80
Effects of endogenous endothelin on in vivo renal microvessels of the rat 79
The post-prandial state in Type 2 diabetes and endothelial dysfunction: effects of insulin aspart 79
Cardiovascular risk factors in patients with carotid stenosis 77
Systemic and intratubular effects of cyclosporin-A and tacrolimus on the rat kidney 76
Effects of n-3 polyunsatured fatty acids (PUFA) on markers of oxidative stress in hypertension 75
The new cardiovascular risk factors in hypertensive patients with metabolic syndrome 73
Prevalence of diabetes and comorbidities in symptomatic peripheral artery disease 72
Serum levels of IL-2, sIL-2R and insulin autoantibodies in children with newly diagnosed insulin-dependent diabetes mellitus 70
null 70
Effects of endothelium-derived relaxing factor (EDRF) on renal microvessels and pressure-dependent vasodilation 67
Different cell signaling pathways for angiotensin II and Thromboxane-A2 in renal microcirculation 67
Ciclosporina e tacrolimus nella miosite da corpi inclusi: efficacia clinica, sicurezza e risparmio nell'uso dei corticosteroidi 67
Increased circulating levels of ICAM-1 in Type-II diabetic patients - The role of oxidative stress and metabolic control 66
Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: the possible role of metabolic control and oxidative stress 65
Clinical assessment of renal vascular involvement and clinical-pathological correlations 65
Association of a prothrombotic state with the metabolic syndrome in essential hypertensive patients 64
Expression of erythropoietin mRNA in the rat liver: the role of liver regeneration 63
Effects of omega-3 PUFA on plasma lipoprotein(a) in hypertensive patients 63
Endotoxin as a priming co-factor for experimental acute reflux pancreatitis in the rat 61
Effects of protein kinase C inhibition on vasoconstrictor response in the rat kidney 60
Priming effect of endotoxin in liver damage caused by experimental duodenal obstruction in the rat 60
Oxidative stress is produced during meal in NIDDM patients 58
Angioplastica carotidea in pazienti a rischio cerebrovascolare: fattori di rischio e outcome a 3 anni 57
Alterazioni emoreologiche in corso di retinopatia diabetica. [Hemorheological changes in diabetic retinopathy]. 56
Visualization of effects of ET-A receptor blockade with BQ-123 on renal hemodynamics in the split hydronephrotic kidneys of rats 55
Dose effects of endothelin-1 and endothelin-3 in an in vivo model of renal microcirculation 55
The renin-angiotensin-aldosterone system in hypertensive patients with nephrosclerosis and incipient renal failure 54
CICLOSPORINA E TACROLIMUS NELLE MIOSITE DEI CORPI INCLUSI 54
Viscoelastic properties of durum wheat doughs enriched with soluble dietary fibres in relation to pasta-making performance and glycaemic response of spaghetti 54
The renin-angiotensin-aldosterone system in early renal failure 53
The emerging risk factors for cardiovascular disease: a review of the epidemiologic evidence for lipoprotein(a), homocysteine, and fibrinogen 53
Influenza della Lp(a) sull'efficacia a lungo termine della procedura di rivascolarizzazione endovascolare agli arti inferiori nel diabetico 53
n-3 polyunsaturated fatty acids (PUFA) decrease lipoprotein(a) levels in hypertensive patients 52
null 52
n-3 polyunsaturated fatty acids (PUFA) decrease markers of oxidative stress in hypertensive patients. 51
Calcitonina: patologia, clinica e indicazioni farmacologiche. [Calcitonin: pathology, clinical aspects and pharmacologic indications]. 51
The anti-hypertensive drugs can prevent the endothelial dysfunction and the oxidative stress induced by alcohol in in vitro human endothelial cell model 50
Arteriopatia obliterante degli arti inferiori nel diabetico: dati preliminari sull'efficacia a lungo termine della rivascolarizzazione endovascolare 50
Angioplastica degli arti inferiori in diabetici e non diabetici con arteriopatia obliterante degli arti inferiori: dati di follow-up a 5 anni . 48
N-3 polyunsatured fatty acids (PUFA) decreased markers of oxidative stress in hypertensive patients 48
Arteriopatia periferica nel diabetico: quali differenze tra uomini e donne? 47
Angioplastica carotidea in pazienti a rischio di eventi cerebrovascolari: analisi dei fattori di rischio e outcome a 1 anno 45
Renal abnormalities in primary aldosteronism 45
Le oligo-anurie 44
Anomalie renali in pazienti con iperaldosteronismo primitivo: dati di un follow-up a medio-lungo termine 44
Ruolo dell'endotelina e dell'endothelum-derived relaxing factor nella microcircolazione renale 44
Valutazione cinetica della formazione dell'emoglobina glicosilata. [Kinetic evaluation of the formation of glycosylated hemoglobin]. 43
Percutaneous transluminal angioplasty in diabetic and non diabetic peripheral artery disease: Results of a 5-year follow-up study [Angioplastica degli arti inferiori in diabetici e non diabetici con arteriopatia obliterante degli arti inferiori: dati di follow-upa 5 anni] 41
La Sindrome epato-renale. 37
Valutazione del rischio cardiovascolare e follow-up a 1 anno in soggetti sottoposti ad angioplastica carotidea 37
Effects of n-3 polyunsaturated fatty acids (PUFA) on "minor" cardiovascular risk factors in hypertension 35
Effects of omega-3 PUFA on oxidative stress in hypertensive patients 35
I Farmaci dell'emostasi (antitrombotici ed emostatici) 33
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 33
The emergent cardiovascular risk factors in patients with primary aldosteronism 32
Raccomandazioni per la prevenzione e cura dell'arteriopatia periferica nel paziente diabetico 31
Glucose metabolism is unaltered in primary aldosteronism 31
The new cardiovascular risk factors in hypertensive patients with the metabolic syndrome 30
Dulaglutide reduces binge episodes in type 2 diabetic patients with binge eating disorder: A pilot study 30
AORTIC STIFFNESS AND INDEXES OF DISEASE SEVERITY IN SUBJECTS WITH PREVIOUS COVID-19 PNEUMONIA: A FOLLOW-UP STUDY 29
I nuovi fattori di rischio cardiovascolare nei pazienti con iperaldosteronismo primitivo 29
Proprietà strutturali di pasta arricchita di fibre dietetiche e digeribilità dell'amido 28
L'endotelina nella fisiopatologia dell'emodinamica renale: dalle evidenze sperimentali alle implicazioni cliniche 28
Effects of antithrombotic agents on ophthalmological outcomes, cardiovascular risk, and mortality in hypertensive patients with retinal vein occlusion: An exploratory retrospective study 26
Interactions between vitamin D levels, cardiovascular risk factors, and atherothrombosis markers in patients with symptomatic peripheral artery disease 21
Totale 6.887
Categoria #
all - tutte 20.749
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.749


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019371 0 0 0 0 0 0 0 0 0 61 190 120
2019/20201.755 84 111 44 206 129 309 184 217 119 155 52 145
2020/20211.082 26 111 21 170 21 144 36 124 198 35 140 56
2021/2022885 25 88 140 61 47 21 36 41 6 125 167 128
2022/2023852 110 53 15 111 85 230 5 56 124 12 24 27
2023/2024277 51 23 9 5 60 61 11 10 42 5 0 0
Totale 7.039